Ustekinumab vs Infliximab in CD
Filgotinib in small bowel Crohn’s disease
Ritlecitinib and Brepocitinib in UC
Vedolizumab in chronic pouchitis
Infliximab or azathioprine withdrawal in CD
Etrasimod in UC
Diverting ileostomy closure after pouch construction
Vedolizumab, adalimumab and methotrexate combination in CD
Tofacitinib in acute severe ulcerative colitis
Phase 2 trial, guselkumab in Crohn’s disease efficacy and safety at week 48